Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma

This study has been completed.
Sponsor:
Collaborator:
Pfizer
Information provided by:
Nycomed
ClinicalTrials.gov Identifier:
NCT01365533
First received: May 30, 2011
Last updated: May 4, 2012
Last verified: May 2012